Human CTLA-4 antibodies
US6984720B1 · kind B1 · utility
252Cited by
62References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2000 |
| Grant date | Jan 10, 2006 |
| Priority date | — |
| Expiry date | Aug 2, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides human sequence antibodies against CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.